{"id":6461,"date":"2026-02-26T11:55:00","date_gmt":"2026-02-26T10:55:00","guid":{"rendered":"https:\/\/www.theras-group.com\/diabetes-management\/terapia-multi-iniettiva-con-port\/"},"modified":"2026-07-13T11:24:50","modified_gmt":"2026-07-13T09:24:50","slug":"multi-injection-access-port-therapy","status":"publish","type":"page","link":"https:\/\/www.theras-group.com\/en\/diabetes-management\/multi-injection-access-port-therapy\/","title":{"rendered":"Multi-injection access port therapy"},"content":{"rendered":"\n\n\t

Multi-injection access port therapy<\/strong><\/h1>\n\t

Discreet and targeted diabetes management.<\/p>\n\t

A delivery mode designed for comfort.<\/strong><\/p>\n\t

Multi-injection therapy involves administering insulin via several daily injections. By using a subcutaneous access port<\/strong> it is possible to simplify this routine, reducing the number of times it is necessary to puncture the skin everyday and improving the patient’s quality of life.<\/p>\n\t

How multi-injection port therapy works<\/h2>\n\t

Multi-injection port therapy involves using a small device applied via an adhesive to the skin<\/b>, know as a ‘port’ (or subcutaneous access port). This port allows insulin to be administered through multiple daily injections, without having to puncture the skin each time<\/b>.\u00a0 When administering an injection, the insulin pen needle enters the port<\/b> and not the skin, rendering the procedure less painful and more comfortable, especially for people with diabetes who need several injections everyday.<\/p>\n\t

The components.<\/h2>\n\t
    \n
  1. An access port<\/strong> or subcutaneous insulin injections.<\/li>\n
  2. An applicator<\/strong> for automatic, simple, and painless port insertion.<\/li>\n<\/ol>\n\t

    Simplify your routine.<\/h2>\n\t

    1<\/p>\n\t

    Fewer daily injections: <\/strong>the device administers insulin via the same access point over a period of several days, without having to repeat the injection directly via the skin.<\/p>\n\t

    2<\/p>\n\t

    Greater therapeutic adherence:<\/strong> thanks to the reduced physical discomfort, many patients tend to be more regular with their insulin administrations.<\/p>\n\t

    3<\/p>\n\t

    Discretion and freedom:<\/strong> the port is barely visible and allows for greater discretion, especially in social and work contexts.<\/p>\n\t

    The value of a tailor-made choice.<\/p>\n\tMulti-injection port therapy represents an effective and less invasive option
    \nfor many people with diabetes. It enables patients to simplify day-to-day management
    \nof diabetes while maintaining effective control over their therapy.\n\tSources<\/strong>
    \n– Burdick et al. 2009. “Use of a subcutaneous injection port to improve glycemic control in children with type 1 diabetes”
    \n– Maltoni et al. 2018- “Using an injection port helps improve metabolic control and compliance to a strict basal-bolus regimen in children and adolescents with type 1 diabetes”
    \n– International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024
    \n– Khan et al. 2018. “Benefits of Using the i-Port System on Insulin-Treated Patients”\n\n","protected":false},"excerpt":{"rendered":"

    \nMulti-injection access port therapy Discreet and targeted diabetes management. A delivery mode designed for comfort. Multi-injection therapy involves administering insulin via several daily injections. By using a subcutaneous access port…\n<\/div>\n","protected":false},"author":1,"featured_media":0,"parent":6309,"menu_order":35,"comment_status":"closed","ping_status":"closed","template":"templates\/no-title.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-6461","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"\nTheras Group \u00e8 in prima linea nella prevenzione e correzione del diabete<\/title>\n<meta name=\"description\" content=\"L'innovazione sperimentale di Theras fissa come obiettivo la ricerca di soluzioni in grado di prevenire e correggere le complicanze dovute al diabete.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.theras-group.com\/en\/diabetes-management\/multi-injection-access-port-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Theras Group \u00e8 in prima linea nella prevenzione e correzione del diabete\" \/>\n<meta property=\"og:description\" content=\"L'innovazione sperimentale di Theras fissa come obiettivo la ricerca di soluzioni in grado di prevenire e correggere le complicanze dovute al diabete.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.theras-group.com\/en\/diabetes-management\/multi-injection-access-port-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Theras Group\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/theras.care\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-13T09:24:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.theras-group.com\/wp-content\/uploads\/2025\/01\/Theras_WS_IMG_2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.theras-group.com\\\/en\\\/diabetes-management\\\/multi-injection-access-port-therapy\\\/\",\"url\":\"https:\\\/\\\/www.theras-group.com\\\/en\\\/diabetes-management\\\/multi-injection-access-port-therapy\\\/\",\"name\":\"Theras Group \u00e8 in prima linea nella prevenzione e correzione del diabete\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.theras-group.com\\\/#website\"},\"datePublished\":\"2026-02-26T10:55:00+00:00\",\"dateModified\":\"2026-07-13T09:24:50+00:00\",\"description\":\"L'innovazione sperimentale di Theras fissa come obiettivo la ricerca di soluzioni in grado di prevenire e correggere le complicanze dovute al diabete.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.theras-group.com\\\/en\\\/diabetes-management\\\/multi-injection-access-port-therapy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.theras-group.com\\\/en\\\/diabetes-management\\\/multi-injection-access-port-therapy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.theras-group.com\\\/en\\\/diabetes-management\\\/multi-injection-access-port-therapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.theras-group.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diabetes Management\",\"item\":\"https:\\\/\\\/www.theras-group.com\\\/en\\\/diabetes-management\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Multi-injection access port therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.theras-group.com\\\/#website\",\"url\":\"https:\\\/\\\/www.theras-group.com\\\/\",\"name\":\"Theras Group\",\"description\":\"Theras Group al centro dell'innovazione tecnologica in ambito medico\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.theras-group.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.theras-group.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.theras-group.com\\\/#organization\",\"name\":\"Theras Group\",\"url\":\"https:\\\/\\\/www.theras-group.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.theras-group.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/logo-1.png\",\"contentUrl\":\"\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/logo-1.png\",\"width\":344,\"height\":88,\"caption\":\"Theras Group\"},\"image\":{\"@id\":\"https:\\\/\\\/www.theras-group.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/theras.care\\\/\",\"https:\\\/\\\/www.instagram.com\\\/therasgroup\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/theras-group\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Theras Group \u00e8 in prima linea nella prevenzione e correzione del diabete","description":"L'innovazione sperimentale di Theras fissa come obiettivo la ricerca di soluzioni in grado di prevenire e correggere le complicanze dovute al diabete.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.theras-group.com\/en\/diabetes-management\/multi-injection-access-port-therapy\/","og_locale":"en_US","og_type":"article","og_title":"Theras Group \u00e8 in prima linea nella prevenzione e correzione del diabete","og_description":"L'innovazione sperimentale di Theras fissa come obiettivo la ricerca di soluzioni in grado di prevenire e correggere le complicanze dovute al diabete.","og_url":"https:\/\/www.theras-group.com\/en\/diabetes-management\/multi-injection-access-port-therapy\/","og_site_name":"Theras Group","article_publisher":"https:\/\/www.facebook.com\/theras.care\/","article_modified_time":"2026-07-13T09:24:50+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.theras-group.com\/wp-content\/uploads\/2025\/01\/Theras_WS_IMG_2.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.theras-group.com\/en\/diabetes-management\/multi-injection-access-port-therapy\/","url":"https:\/\/www.theras-group.com\/en\/diabetes-management\/multi-injection-access-port-therapy\/","name":"Theras Group \u00e8 in prima linea nella prevenzione e correzione del diabete","isPartOf":{"@id":"https:\/\/www.theras-group.com\/#website"},"datePublished":"2026-02-26T10:55:00+00:00","dateModified":"2026-07-13T09:24:50+00:00","description":"L'innovazione sperimentale di Theras fissa come obiettivo la ricerca di soluzioni in grado di prevenire e correggere le complicanze dovute al diabete.","breadcrumb":{"@id":"https:\/\/www.theras-group.com\/en\/diabetes-management\/multi-injection-access-port-therapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.theras-group.com\/en\/diabetes-management\/multi-injection-access-port-therapy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.theras-group.com\/en\/diabetes-management\/multi-injection-access-port-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.theras-group.com\/en\/"},{"@type":"ListItem","position":2,"name":"Diabetes Management","item":"https:\/\/www.theras-group.com\/en\/diabetes-management\/"},{"@type":"ListItem","position":3,"name":"Multi-injection access port therapy"}]},{"@type":"WebSite","@id":"https:\/\/www.theras-group.com\/#website","url":"https:\/\/www.theras-group.com\/","name":"Theras Group","description":"Theras Group al centro dell'innovazione tecnologica in ambito medico","publisher":{"@id":"https:\/\/www.theras-group.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.theras-group.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.theras-group.com\/#organization","name":"Theras Group","url":"https:\/\/www.theras-group.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.theras-group.com\/#\/schema\/logo\/image\/","url":"\/wp-content\/uploads\/2024\/11\/logo-1.png","contentUrl":"\/wp-content\/uploads\/2024\/11\/logo-1.png","width":344,"height":88,"caption":"Theras Group"},"image":{"@id":"https:\/\/www.theras-group.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/theras.care\/","https:\/\/www.instagram.com\/therasgroup\/","https:\/\/www.linkedin.com\/company\/theras-group\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.theras-group.com\/en\/wp-json\/wp\/v2\/pages\/6461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.theras-group.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.theras-group.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.theras-group.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.theras-group.com\/en\/wp-json\/wp\/v2\/comments?post=6461"}],"version-history":[{"count":5,"href":"https:\/\/www.theras-group.com\/en\/wp-json\/wp\/v2\/pages\/6461\/revisions"}],"predecessor-version":[{"id":6626,"href":"https:\/\/www.theras-group.com\/en\/wp-json\/wp\/v2\/pages\/6461\/revisions\/6626"}],"up":[{"embeddable":true,"href":"https:\/\/www.theras-group.com\/en\/wp-json\/wp\/v2\/pages\/6309"}],"wp:attachment":[{"href":"https:\/\/www.theras-group.com\/en\/wp-json\/wp\/v2\/media?parent=6461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}